Annual ROA
-145.62%
+36.56%+20.07%
31 December 2023
Summary:
Galectin Therapeutics annual return on assets is currently -145.62%, with the most recent change of +36.56% (+20.07%) on 31 December 2023. During the last 3 years, it has fallen by -66.35% (-83.70%). GALT annual ROA is now -430.88% below its all-time high of -27.43%, reached on 31 December 2019.GALT ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-162.85%
+7.63%+4.48%
30 September 2024
Summary:
Galectin Therapeutics quarterly return on assets is currently -162.85%, with the most recent change of +7.63% (+4.48%) on 30 September 2024. Over the past year, it has increased by +36.32% (+18.24%). GALT quarterly ROA is now -2688.53% below its all-time high of -5.84%, reached on 31 March 2007.GALT Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.1% | +18.2% |
| 3 y3 years | -83.7% | -61.9% |
| 5 y5 years | +5.7% | -338.1% |
GALT ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -99.5% | +20.1% | -81.6% | +18.8% |
| 5 y | 5 years | -430.9% | +20.1% | -452.2% | +18.8% |
| alltime | all time | -430.9% | +91.5% | -2688.5% | +83.0% |
Galectin Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -162.85%(-4.5%) |
| June 2024 | - | -170.48%(+0.1%) |
| Mar 2024 | - | -170.36%(-6.0%) |
| Dec 2023 | -145.62%(-20.1%) | -181.17%(-9.0%) |
| Sept 2023 | - | -199.17%(-0.7%) |
| June 2023 | - | -200.60%(+6.0%) |
| Mar 2023 | - | -189.29%(+20.5%) |
| Dec 2022 | -182.18%(+149.6%) | -157.15%(+32.5%) |
| Sept 2022 | - | -118.63%(+17.1%) |
| June 2022 | - | -101.28%(+9.0%) |
| Mar 2022 | - | -92.92%(+3.6%) |
| Dec 2021 | -72.98%(-7.9%) | -89.68%(-10.8%) |
| Sept 2021 | - | -100.56%(+5.5%) |
| June 2021 | - | -95.31%(+16.1%) |
| Mar 2021 | - | -82.11%(+30.4%) |
| Dec 2020 | -79.27%(+189.0%) | -62.96%(+27.4%) |
| Sept 2020 | - | -49.42%(+29.7%) |
| June 2020 | - | -38.11%(+29.2%) |
| Mar 2020 | - | -29.49%(-11.2%) |
| Dec 2019 | -27.43%(-82.2%) | -33.22%(-10.6%) |
| Sept 2019 | - | -37.17%(-33.1%) |
| June 2019 | - | -55.55%(-55.3%) |
| Mar 2019 | - | -124.33%(-20.0%) |
| Dec 2018 | -154.34%(-60.4%) | -155.47%(-9.2%) |
| Sept 2018 | - | -171.19%(-21.5%) |
| June 2018 | - | -218.04%(-10.9%) |
| Mar 2018 | - | -244.67%(+30.0%) |
| Dec 2017 | -390.17%(+187.5%) | -188.24%(+17.7%) |
| Sept 2017 | - | -159.92%(+19.0%) |
| June 2017 | - | -134.42%(+10.1%) |
| Mar 2017 | - | -122.04%(+3.8%) |
| Dec 2016 | -135.71%(+78.9%) | -117.55%(+14.1%) |
| Sept 2016 | - | -103.00%(+0.1%) |
| June 2016 | - | -102.87%(+13.8%) |
| Mar 2016 | - | -90.37%(+18.0%) |
| Dec 2015 | -75.84%(+42.6%) | -76.60%(+8.2%) |
| Sept 2015 | - | -70.80%(+24.6%) |
| June 2015 | - | -56.84%(+15.1%) |
| Mar 2015 | - | -49.39%(+3.6%) |
| Dec 2014 | -53.20%(-52.8%) | -47.67%(-8.9%) |
| Sept 2014 | - | -52.34%(-19.1%) |
| June 2014 | - | -64.71%(-27.6%) |
| Mar 2014 | - | -89.40%(-39.2%) |
| Dec 2013 | -112.83%(+11.5%) | -146.92%(0.0%) |
| Sept 2013 | - | -146.92%(+12.7%) |
| June 2013 | - | -130.36%(+23.1%) |
| Mar 2013 | - | -105.91%(+35.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -101.19%(-38.7%) | -78.00%(-14.7%) |
| Sept 2012 | - | -91.43%(-0.5%) |
| June 2012 | - | -91.85%(-15.8%) |
| Mar 2012 | - | -109.06%(-25.1%) |
| Dec 2011 | -165.08%(+84.8%) | -145.54%(+30.5%) |
| Sept 2011 | - | -111.50%(-6.9%) |
| June 2011 | - | -119.76%(-1.0%) |
| Mar 2011 | - | -120.91%(-32.1%) |
| Dec 2010 | -89.35%(-94.8%) | -178.08%(-45.7%) |
| Sept 2010 | - | -327.79%(-35.0%) |
| June 2010 | - | -504.64%(-47.4%) |
| Mar 2010 | - | -959.59%(+23.9%) |
| Dec 2009 | -1711.47%(+282.4%) | -774.47%(+4.7%) |
| Sept 2009 | - | -739.74%(+39.0%) |
| June 2009 | - | -532.16%(+83.7%) |
| Mar 2009 | - | -289.62%(+79.0%) |
| Dec 2008 | -447.59%(-15.4%) | -161.78%(-1.6%) |
| Sept 2008 | - | -164.35%(-40.6%) |
| June 2008 | - | -276.60%(+21.6%) |
| Mar 2008 | - | -227.39%(-31.5%) |
| Dec 2007 | -529.35%(+954.9%) | -332.15%(+48.9%) |
| Sept 2007 | - | -223.12%(+1913.7%) |
| June 2007 | - | -11.08%(+89.7%) |
| Mar 2007 | - | -5.84%(-74.7%) |
| Dec 2006 | -50.18%(-61.9%) | -23.09%(-33.6%) |
| Sept 2006 | - | -34.80%(-71.7%) |
| June 2006 | - | -122.97%(-21.4%) |
| Mar 2006 | - | -156.52%(+73.0%) |
| Dec 2005 | -131.86%(+104.0%) | -90.49%(+14.1%) |
| Sept 2005 | - | -79.29%(+16.5%) |
| June 2005 | - | -68.06%(+7.6%) |
| Mar 2005 | - | -63.26%(-11.7%) |
| Dec 2004 | -64.63%(+6.1%) | -71.64%(+0.5%) |
| Sept 2004 | - | -71.31%(-15.9%) |
| June 2004 | - | -84.79%(-18.1%) |
| Mar 2004 | - | -103.50%(-4.8%) |
| Dec 2003 | -60.90%(-62.2%) | -108.73%(-25.0%) |
| Sept 2003 | - | -144.88%(-15.4%) |
| June 2003 | - | -171.17%(-11.4%) |
| Mar 2003 | - | -193.15%(-16.9%) |
| Dec 2002 | -161.11%(-28.3%) | -232.35%(-32.6%) |
| Sept 2002 | - | -344.90%(-7.8%) |
| June 2002 | - | -373.88%(+2.9%) |
| Mar 2002 | - | -363.33%(+25.3%) |
| Dec 2001 | -224.76% | -289.93%(+137.5%) |
| Sept 2001 | - | -122.09%(+90.6%) |
| June 2001 | - | -64.07% |
FAQ
- What is Galectin Therapeutics annual return on assets?
- What is the all time high annual ROA for Galectin Therapeutics?
- What is Galectin Therapeutics annual ROA year-on-year change?
- What is Galectin Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly ROA year-on-year change?
What is Galectin Therapeutics annual return on assets?
The current annual ROA of GALT is -145.62%
What is the all time high annual ROA for Galectin Therapeutics?
Galectin Therapeutics all-time high annual return on assets is -27.43%
What is Galectin Therapeutics annual ROA year-on-year change?
Over the past year, GALT annual return on assets has changed by +36.56% (+20.07%)
What is Galectin Therapeutics quarterly return on assets?
The current quarterly ROA of GALT is -162.85%
What is the all time high quarterly ROA for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly return on assets is -5.84%
What is Galectin Therapeutics quarterly ROA year-on-year change?
Over the past year, GALT quarterly return on assets has changed by +36.32% (+18.24%)